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ACUTE RESPIRATORY INFECTIONS IN CIVILIAN ADULTS 
I I . Chnical and Serologic Observations in a Vaccine Study Group 
F. Cox, JR., M.D.,* E. A. T I M M , * * I . W. M C L E A N , * * * 
C. F. WEISS,**** AND E . L . QUINN, M.D.* 
I N RECENT YEARS numerous reports have been published concerning the efficacy of 
killed influenza and adenovirus vaccines in the prevention or modification of iOness 
due to these viral agents. It has been established that such vaccines conferred a signifi-
cant degree of protection during epidemic outbreaks of acute respiratory infection 
due to the various types of influenza in civilian and military groups and against adeno-
virus outbreaks in military recruits.'"'' It has also been shown that multiple influenza 
and adenoviruses may be combined in a single vaccine without loss of antigenic 
efficiency of the individual antigens in the mixture.' 
A study to determine the clinical efficacy of several polyvalent influenza, adeno-
virus and parainfluenza vaccines in a heterogeneous adult civilian population group 
was begun in September, 1959 as part of a continuing respiratory infection investiga-
tion program. Four months after the institution of this study, an epidemic outbreak 
of Asian influenza occured in the Detroit area. This chance happening presented an 
opportunity to observe the protective rate of the various polyvalent vaccines in pre-
vention of an epidemic illness due to one agent (Influenza A2) contained in certain 
of the vaccines under study. 
MATERIALS AND METHODS 
Three hundred adult hospital employees volunteeded to participate in the study. Two 
hundred and forty of the subjects had never received respiratory virus vaccines. They were 
divided into four equal groups of 60 each by random selection. The remaining 60 subjects 
received either influenza or adenovirus vaccine or a placebo in the previous two years, but 
not more recently than 12 months before. These subjects were divided by random selection 
into two groups of 30 each resulting in a total of six groups. The vaccine administered to 
each group and the number of subjects completing the study is presented in Table I . The 
vaccines were coded by the statistician and neither the subjects, clinical observers or labor-
atory investigators had knowledge of the composition of material given any subject until 
all clinical and serologic data were completed. Commercially prepared vaccines and a 
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Table I 
Composition of Vaccines and Division of Subjects into Groups 
Test Vaccines 
Influenza 
Influenza-Adenovirus 
Influenza-Adenovirus-Parainfluenza 
Placebo 
Adenovirus 
Parainfluenza 
Total 
No. of Subjects 
57 
60 
58 
59 
28 
29 
291 
placebo were employed. The influenza vaccine contained PR-8, A / A A '57, Great Lakes 
and Asian strains combined in a final concentration of 100, 100, 100 and 200 CCA units 
respectively per ml. of final vaccine. The pooled adenovirus vaccine contained Types 3, 4 
and 7 strains and the Parainfluenza Types 1 and 3 strains. Each vaccine and the placebo 
also contained 3.5 mg. of ALPOj per ml. and Merthiolate 1:10,000. Polyvalent influenza, 
infltjenza-adenovirus, influenza-adenovirus-parainfluenza or placebo were administered to 
subjects who had never received prior vaccination. Adenovirus or parainfluenza vaccine was 
given to the previously vaccinated group. 
One ml. of vaccine or placebo was administered to each subject subcutaneously in the 
left deltoid at the outset of the study (Sept., 1959) and a second injection was given one 
month later. Blood was obtained for serologic testing at 0, 4 and 8 weeks. In March, 1960 
at the termination of the Asian Influenza epidemic, all subjects were again bled and the sera 
were paired with the previous specimens. Asian influenza hemagglutination inhibition titers' 
of the coded sera were determined in the laboratory of Drs. McLean and Timm. A four-
fold increase in titer between the 8th week (Oct., 1959) blood and 24th week (March, 1960) 
blood specimens was considered to represnt serologic evidence of Asian influenza infection. 
A l l participants were interviewed by a nurse assigned to the study once every two weeks 
and were also instructed to report to the clinic at the time of onset of any acute respiratory 
or febrile illness. A special study history form was completed by the nurse at each visit. 
I f the temperature was 100° F or more, the subject was examined by one of us (F. C. or 
E. Q.) and a throat culture for Beta hemolytic streptococci obtained. Based on the history 
examination and results of the throat culture, a clinical impression was formulated. Subjects 
who were afebrile with localized acute respiratory symptoms were classified as having a 
Common Cold. In subjects with a temperature of 100° or above with systemic as well as 
acute respiratory symptoms. Acute Respiratory Disease was diagnosed. Streptococcal sore 
throat was not encountered during the study period under analysis. The clinical diagnosis 
served as a rough estimate of the severity of the acute respiratory illness. 
The clinical data were correlated later with the presence or absence of a four-fold 
rise in Asian influenza titer by employment of computer analysis of the data.* The corre-
lation of clinical illness and antibody titer changes to other antigens in test vaccines wi l l be 
the subject of a later report. 
R E S U L T S 
The 1960 epidemic outbreak of Asian influenza previously mentioned is depicted 
in Figure 1. The top two graphs illustrate the number of cases of "pneumonia" and 
"influenza" reported to the Detroit Department of Health**, before, during and after 
this epidemic. The lower graph shows the biweekly rate of all respiratory illness that 
occurred in the entire study group between Nov., 1959 and Dec , 1960. A sharp 
rise in incidence of respiratory illness occurred early in 1960, suggesting that our 
•Accomplished by R. R. Gauch, Parke, Davis & Co., Ann Arbor, Michigan. 
*Data on the incidence of influenza and pneumonia, and permission to use the data kindly supplied 
by Drs. Joseph G, Molner and Charles P. Anderson, Detroit Department of Health. 
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volunteer group had probably experienced the same epidemic outbreak that was 
observed in the general population. 
The incidence of occurrence of a four-fold rise in Asian influenza antibody titer 
in the hospital study group is presented in Table I I . This and subsequent tables give 
the rate per 100 subjects, or percentage. Those subjects who received placebo or 
vaccine which did not contain Asian influenza antigen are tabulated in the non-
protected group, while those who received a vaccine containing Asian influenza 
antigen are listed in the protected group. This table also depicts the incidence of sero-
logic evidence of infection in the absence of a respiratory illness and the association 
of both serologic and clinical evidence of an acute respiratory illness. 
Table I I 
Incidence of Four-Fold Rise in Asian Influenza Antibody 
Titer between October, 1959 and March, 1960 
Not Associated with 
Respiratory Illness 
Associated with 
Respiratory Illness 
Non-Protected Groups 
Placebo 5% 
Adenovirus 7% Aver. 5% 
Parainfluenza 3% 
Protected Groups 
Influenza 7% 
Influenza-Adenovirus 0% Aver. 4% 
Influenza-Adenovirus-Parainfluenza 5 % 
Protection Rate 
15% 
28.5% Aver. 19.2% 
14% 
7% 
5% Aver. 4% 
0% 
79.7% (P = .05) 
These data indicate that serologic response without clinical evidence of infection 
occurred with approximately equal frequency in both the non-protected and protected 
groups. In contrast when both serologic and clinical evidence of acute respiratory 
infection was observed, the incidence was 19.2 per cent in the unprotected group 
and 4 per cent in the protected group, representing a protection rate of 79 per cent. 
This difference is statistically significant. (P value = .05) Among the protected 
groups it is of interest to note that clinical infection did not occur in the group that 
received the combined influenza-adenovirus-parainfluenza vaccine while the rate for 
the other two groups was 7 and 5 per cent. This difference is on the borderline of 
statistical significance and cannot be explained on the basis of difference in pre-
epidemic antibody titer since these titers were essentially similar in the three groups. 
It is attractive to speculate that the addition of parainfluenza antigen to the vaccine 
was responsible for the enhanced protection, but the number of subjects is too small 
to permit this conclusion. 
Since acute respiratory illness associated with a four-fold rise in Asian influenza 
antibody titer occurred in both the non-protected and protected groups (although at 
a lower rate in the latter) it was of interest to determine if vaccination exerted any 
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Table I I I 
Severity of Respiratory Illness Associated with a Four-Fold Rise in Asian Influenza 
Antibody Titer as Determined by the Clinical Diagnoses and Duration of Illness 
Non-Protected Group Protected Group 
1. Clinical Diagnosis: 
Common Cold 33% 36% 
ARD-Influenza 60% 64% 
Pneumonia 4% 0% 
2. Duration of Iflness: 
1-3 days 28% 22% 
4-7 days 40% 44% 
8-17 days 20% 33% 
-f- 14 days 10% 0% 
influence on the severity of the illness when it did occur (Table I I I ) . The clinical 
diagnosis and duration of common cold, acute respiratory disease and influenza was 
made with approximately equal frequency in both groups. There was one instance 
of pneumonia in a non-protected subject. Similarly, the duration of illness was essen-
tially the same for the two groups. These data indicate that if a symptomatic respira-
tory illness associated with a diagnostic rise in antibody titer occurred, vaccination 
did not modify the severity of the illness. 
Table IV 
Incidence of Respiratory Illnesses in Absence of Four-Fold Rise in 
Influenza Antibody Titer between January 1, I960 and March 15, 1960 
Non-Protected Groups 
Placebo 45% 
Adenovirus 28.5% Aver. 35.8% 
Parainfluenza 34% 
Protected Groups 
Influenza 26% 
Influenza-Adenovirus 45% Aver. 37% 
Influenza-Adenovirus-Parainfluenza 40% 
Table IV illustrates the incidence of acute respiratory illness not associated with 
a rise in antibody titer to Asian influenza (and therefore presumably respiratory illness 
other than Asian influenza). It is apparent that infection rates were approximately 
equal for both the non-protected and protected groups. 
SUMMARY 
In the course of a study concerning the protective value of inactivated poly-
valent respiratory vaccines an Asian Influenza epidemic occurred. Of six vaccines 
employed in this study, three contained Asian influenza antigen. The incidence of 
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ASIAN INFLUENZA EPIDEMIC 
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Figure 1 
The occurrence of Pneumonia, Influenza and Respiratory Illnesses in Detroit and in the study group. 
serologically proven influenza associated with clinical respiratory illness was 19.2 
per cent in the subjects who did not receive vaccine containing the Asian influenza 
antigen and 4 per cent in the group who did, a protection rate of 79 per cent. These 
figures are comparable to those obtained by other investigators.'"* The severity and 
course of respiratory illness occurring in subjects with four-fold rise in Asian influenza 
antibody titer were the same in the protected and non-protected groups in this study. 
Finally, the protection afforded by the vaccine was specific. 
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